Key Lab publishes study describing rapid and sensitive assay for hyperfibrinolysis in plasma

In collaboration with colleagues in the UK who first described a form of severe post-partum hemorrhage (PPH) characterized by marked hyperfibrinolysis, a novel rapid assay for fibrinolytic activation in plasma developed in the lab (the Fibrinolytic Activation Screening Test or ‘FAST’ assay) reliably distinguished Acute Obstetric Coagulopathy from other forms of PPH in archived plasma samples. The findings are described in an online manuscript in ‘Blood Advances’.